
### [DOID:439](http://purl.obolibrary.org/obo/DOID_439)
**Label:** neuromuscular junction disease

**Subclasses:** [DOID:437](http://purl.obolibrary.org/obo/DOID_437) (myasthenia gravis), [DOID:3635](http://purl.obolibrary.org/obo/DOID_3635) (congenital myasthenic syndrome), 

**Corr. equiv. classes:** [OMIM:PS601462](http://purl.obolibrary.org/obo/OMIM_PS601462), [Orphanet:590](http://www.orpha.net/ORDO/Orphanet_590), [OMIM:254200](http://purl.obolibrary.org/obo/OMIM_254200), 

**Class expressions from DL-Learner:**

- [HP:0001611](http://purl.obolibrary.org/obo/HP_0001611) (Nasal speech) and [HP:0100763](http://purl.obolibrary.org/obo/HP_0100763) (Abnormality of the lymphatic system) 66.67%
- [HP:0001611](http://purl.obolibrary.org/obo/HP_0001611) (Nasal speech) and [HP:0100522](http://purl.obolibrary.org/obo/HP_0100522) (Thymoma) 66.67%
- [HP:0001611](http://purl.obolibrary.org/obo/HP_0001611) (Nasal speech) and [HP:0100521](http://purl.obolibrary.org/obo/HP_0100521) (Neoplasm of the thymus) 66.67%
- [HP:0001611](http://purl.obolibrary.org/obo/HP_0001611) (Nasal speech) and [HP:0030319](http://purl.obolibrary.org/obo/HP_0030319) (Weakness of facial musculature) 66.67%
- [HP:0001611](http://purl.obolibrary.org/obo/HP_0001611) (Nasal speech) and [HP:0030191](http://purl.obolibrary.org/obo/HP_0030191) (Abnormal peripheral nervous system synaptic transmission) 66.67%
- [HP:0001611](http://purl.obolibrary.org/obo/HP_0001611) (Nasal speech) and [HP:0025270](http://purl.obolibrary.org/obo/HP_0025270) (Abnormality of esophagus physiology) 66.67%
- [HP:0001611](http://purl.obolibrary.org/obo/HP_0001611) (Nasal speech) and [HP:0025032](http://purl.obolibrary.org/obo/HP_0025032) (Abnormality of digestive system physiology) 66.67%
- [HP:0001611](http://purl.obolibrary.org/obo/HP_0001611) (Nasal speech) and [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) 66.67%
- [HP:0001611](http://purl.obolibrary.org/obo/HP_0001611) (Nasal speech) and [HP:0012719](http://purl.obolibrary.org/obo/HP_0012719) (Functional abnormality of the gastrointestinal tract) 66.67%
- [HP:0001611](http://purl.obolibrary.org/obo/HP_0001611) (Nasal speech) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) 66.67%
- [HP:0001611](http://purl.obolibrary.org/obo/HP_0001611) (Nasal speech) and [HP:0012535](http://purl.obolibrary.org/obo/HP_0012535) (Abnormal synaptic transmission) 66.67%
- [HP:0001611](http://purl.obolibrary.org/obo/HP_0001611) (Nasal speech) and [HP:0011799](http://purl.obolibrary.org/obo/HP_0011799) (Abnormality of facial soft tissue) 66.67%
- [HP:0001611](http://purl.obolibrary.org/obo/HP_0001611) (Nasal speech) and [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 66.67%
- [HP:0001611](http://purl.obolibrary.org/obo/HP_0001611) (Nasal speech) and [HP:0011514](http://purl.obolibrary.org/obo/HP_0011514) (Abnormality of binocular vision) 66.67%
- [HP:0001611](http://purl.obolibrary.org/obo/HP_0001611) (Nasal speech) and [HP:0011024](http://purl.obolibrary.org/obo/HP_0011024) (Abnormality of the gastrointestinal tract) 66.67%


